Blackhawk CEO Frederick Pels and MindBio Therapeutics Co-Founder Justin Hanka Will Lead Investor Presentation and Q&A Session Wednesday, February 2nd at 3pm Pacific Standard Time
February 1, 7:00 AM
Vancouver, British Columbia – TheNewswire – February 1, 2021 – Blackhawk Growth Corp. (CSE:BLR) (CSE:BLR) (OTC:BLRZF) (Frankfurt:0JJ) (the…
Blackhawk Launches New Website, Corporate Presentation and Engages Investor Relations Professional to Expand Outreach
January 26, 10:00 AM
Vancouver, British Columbia – TheNewswire – January 26, 2021 – Blackhawk Growth Corp. (CSE:BLR) (Frankfurt:0JJ) (the “Company”…
Blackhawk’s MindBio Therapeutics Ahead of Schedule to Complete Phase 1 Clinical Trial Microdosing of Psychedelic Medicines and Provides Updates on Spinout Process
January 24, 7:00 AM
Vancouver, British Columbia – TheNewswire – January 24, 2022 – Blackhawk Growth Corp. (CSE:BLR) (CSE:BLR) (OTC:BLRZF) (Frankfurt:0JJ) (the…
Blackhawk’s MindBio Therapeutics to Develop Psychedelic Medicine in Microdoses Ready for Commercial Use to Treat Major Depressive Disorder
January 17, 7:00 AM
Vancouver, British Columbia – TheNewswire – January 17, 2021 – Blackhawk Growth Corp. (CSE:BLR) (CSE:BLR) (OTC:BLRZF) (Frankfurt:0JJ) (the…
Blackhawk’s TERP Wholesale LLC Receives State-Issued Micro-Business License Allowing for Retail Delivery
January 12, 7:00 AM
Vancouver, British Columbia – TheNewswire – January 12, 2022 – Blackhawk Growth Corp. (the “Company”) (CSE:BLR) (CSE:BLR) (Frankfurt:0JJ)…
Blackhawk’s TERP Wholesale LLC Reports Unaudited $2,503,133 in Gross Revenue for Nine Months Ended September 30th, 2021
January 6, 7:00 AM
 Vancouver, British Columbia – TheNewswire – January 6, 2022 – Blackhawk Growth Corp. (the “Company”) (CSE:BLR) (CSE:BLR)…
Blackhawk’s MindBio Therapeutics to Develop Proprietary Drug Delivery Technology for Psychedelic Medicines
January 4, 7:00 AM
Vancouver, British Columbia – TheNewswire – January 04, 2022 – Blackhawk Growth Corp. (CSE:BLR) (CSE:BLR) (OTC:BLRZF) (Frankfurt:0JJ) (the…
Blackhawk Growth’s Digital Mind Technology Set to Pioneer Novel Treatment in Pain Management in Cancer Patients; Preparations for Phase 1 Clinical Trials Underway
December 20, 7:00 AM
To help reduce opioid reliance, misuse and abuse
Blackhawk Growth Announces Plan to Spin-Out Psychedelic Subsidiaries and Proposes 1:1 Distribution Ratio
December 15, 7:00 AM
 Vancouver, British Columbia – TheNewswire – December 15, 2021 – Blackhawk Growth Corp. (CSE:BLR) (CSE:BLR) (Frankfurt:0JJ) (…